Glucocorticoid Receptor-like Zn(Cys) 4 Motifs in BslI Restriction Endonuclease

BslI restriction endonuclease cleaves the symmetric sequence CCN 7GG (where N=A, C, G or T). The enzyme is composed of two subunits, α and β, that form a heterotetramer (α 2β 2) in solution. The α subunit is believed to be responsible for DNA recognition, while the β subunit is thought to mediate cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular biology 2003-11, Vol.334 (3), p.595-603
Hauptverfasser: Vanamee, Éva Scheuring, Hsieh, Pei-chung, Zhu, Zhenyu, Yates, David, Garman, Elspeth, Xu, Shuang-yong, Aggarwal, Aneel K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BslI restriction endonuclease cleaves the symmetric sequence CCN 7GG (where N=A, C, G or T). The enzyme is composed of two subunits, α and β, that form a heterotetramer (α 2β 2) in solution. The α subunit is believed to be responsible for DNA recognition, while the β subunit is thought to mediate cleavage. Here, for the first time, we provide experimental evidence that BslI binds Zn(II). Specifically, using X-ray absorption spectroscopic analysis we show that the α subunit of BslI contains two Zn(Cys) 4-type zinc motifs similar to those in the DNA-binding domain of the glucocorticoid receptor. This conclusion is supported by genetic analysis of the zinc-binding motifs, whereby amino acid substitutions in the zinc finger motifs are demonstrated to abolish or impair cleavage activity. An additional putative zinc-binding motif was identified in the β subunit, consistent with the X-ray absorption data. These data were corroborated by proton induced X-ray emission measurements showing that full BslI contains at least three fully occupied Zn sites per α/β heterodimer. On the basis of these data, we propose a role for the BslI Zn motifs in protein–DNA as well as protein–protein interactions.
ISSN:0022-2836
1089-8638
DOI:10.1016/j.jmb.2003.09.043